Asia Pacific Omega-3 Market Research Report - Segmented Based on Type, Application, Source, and Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC)- Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast from 2024 to 2029

Updated On: June, 2024
ID: 9763
Pages: 140

Asia Pacific Omega-3 Market Size (2024 to 2029)

Asia Pacific Omega-3 Market size is expected to be at USD 1.32 billion in 2024 and is foreseen to develop up to USD 2.67 billion by the end of 2029 with a considerable growth rate of 15.06 % over the conjecture period 2024 to 2029. 

MARKET DRIVERS

Omega-3s are a family of fats important for health, which are divided into alpha-linolenic acid, eicosapentaenoic acid, and docosahexaenoic acid. The human body cannot prepare ALA (alpha-linolenic acid), so it must be consumed. EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) are long-chain fats that can be made from ALA in our bodies. 

Increased investments by various companies to improve manufacturing capacity, strengthen R&D activities for the production of new products, increase the demand for the production of infant formulas for development and better infant growth, and increase adoption of Omega-3 fatty acids in the animal feed industry to provide improved performance are important factors that are expected to contribute to the growth of the Asia Pacific Omega-3 market during the forecast period 2024 - 2029. Excessive consumption of omega-3 leads to gastrointestinal diseases such as diarrhea, fish breath, upset stomach, and nausea, which are major factors holding back the growth of the Asia Pacific Omega-3 market.

Increased investments by various companies to improve manufacturing capacity, strengthen R&D activities for the production of new products, increase the demand for the production of infant formulas for development and better infant growth, and increase adoption of Omega-3 fatty acids in the animal feed industry to provide improved performance are important factors that are expected to contribute to the growth of the Omega-3 market in the Asia Pacific region, during the outlook period. The importance of omega-3s in infant nutrition in the Asia-Pacific region is unprecedented; and as a result, there is a high demand for omega-3 products.

This growing demand for infant nutrition is driving the omega-3 market in the Asia-Pacific, underpinned by the health attributes it offers for prenatal and postnatal care. China and India are the world's largest consumers of infant formula, due to high birth rates in the countries. China accounted for around a third of the infant formula market in 2015, while infant formula is also the largest food segment, where the average annual delivery exceeds 25 million children.

MARKET RESTRAINTS

However, excessive consumption of omega-3 leads to gastrointestinal diseases such as diarrhea, fish breath, upset stomach, and nausea, which are major factors holding back the growth of the Asia Pacific Omega-3 market. The cost of fish and other marine oils used to extract omega-3s is high and highly unstable. This factor poses a challenge to the growth of the local market. Fluctuating raw material prices negatively affects the omega-3 market. The sudden increase in the prices of these raw materials is due to the increase in the cost of aquaculture.

Food is the main input for aquaculture, and food prices are continually changing due to the high cost of maintaining aquaculture. The cost of imported or purchased fish also increases considerably. Increasing manpower, energy and energy costs and restrictions on deep-sea fishing further slow down the growth of the industry. Therefore, the increase in the prices of raw materials creates a challenge for the growth of the Asia Pacific omega-3 market.

This Research Report on Asia Pacific Omega-3 Market is segmented and segmented into the following categories

Asia Pacific Omega-3 Market Analysis By Type

  • ALA
  • EPA
  • DHA

Depending on the type, the market is divided into eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and alpha-linolenic acid (ALA). The combination of DHA and EPA helps reduce bad cholesterol and coronary heart disease such as stroke and blood pressure, which, in turn, should boost the growth of these segments. In this sense, the higher incidence of heart disease in individuals due to an unhealthy lifestyle is likely to fuel the demand for Omega-3. Due to increased aquaculture activities, mainly in the Asia Pacific. The abundant availability of agricultural land and favourable climatic conditions should stimulate the demand for foods containing Omega-3.

Asia Pacific Omega-3 Market Analysis By Application   

  • Pet Food
  • Feed
  • Infant Formula
  • Pharmaceuticals
  • Functional Foods Beverages
  • Dietary Supplements

In terms of application, the Asia Pacific Omega-3 market is divided into functional foods and supplements, pharmaceuticals, instant formulas, pet food, and more. The functional foods and supplements segment dominated the industry in 2019 due to the various health benefits of omega-3 fatty acids, rising R&D initiatives, and rising healthcare costs. The increasing use of dietary supplements to maintain fitness and nutrient adequacy in adults should increase Omega-3 consumption in dietary supplements. Supplements and functional foods are consumed primarily to ensure the supply of important nutritional components for the human body. The increase in the number of cardiovascular diseases due to the slow and inactive lifestyle, especially in the age group of 30 to 40 years, and fluctuating diets are the factors that should drive the importance of Omega-3 nutraceutical products in the market in the coming years.

Asia Pacific Omega-3 Market Analysis By Source  

  • Plant
  • Marine

Depending on the source, the omega-3 industry falls into two categories, namely marine sources, and plant sources. In terms of revenue, the marine source of Omega-3 fatty acids accounted for an 82.5% share in 2019 and should experience significant growth during the forecast period. Demand for marine products is fuelled by growing consumer interest in Omega-3 fatty acids extracted from fish and krill oils. Increased consumption of Omega-3s in the form of fortified food products, such as fish ham and fish sausages, should stimulate the segment in the coming years. Furthermore, increasing awareness of consuming high triglycerides is expected to drive demand for omega-3 fortified foods.

Asia Pacific Omega-3 Market Analysis By Country

  • China
  • Taiwan
  • South Korea
  • India
  • Japan
  • Australia
  • New Zealand

The Asia Pacific Omega-3 market has been divided by geography into China, Taiwan, South Korea, India, Japan, Australia, and New Zealand, and the rest of the Asia-Pacific. Asia-Pacific is supposed to experience considerable growth over the forecast period due to the growing demand for products in the countries mentioned above. The increased consumption of fish oil in the daily diet, as well as greater health awareness, increases the demand for Omega-3 in this region. Furthermore, the growing cultivation of krill in the South China Sea and the Indian Ocean should boost the growth of the regional market in the coming years.

KEY PLAYERS IN ASIA PACIFIC OMEGA-3 MARKET

Key Players In Asia Pacific Omega-3 Market are Cargill, Pharma Marine AS, Luhua Biomarine (Shandong) Co., Ltd, GC Rieber Oils, Omega Protein Corporation, OLVEA Fish Oils, Royal DSM, Croda International Plc, FMC Corporation.

RECENT HAPPENINGS IN THE ASIA PACIFIC OMEGA-3 MARKET

  • In October 2019, KD Pharma introduced Kardio3, which is a blend of omega-3s, vitamin K2, and phytosterols. It helps maintain healthy lipids and supports heart and bone health.
  • In September 2019, Polaris introduced Omegavie DHA 700 algae Sensory QualitySilver, which is supposed to aid the company in the omega-3 algae sector. The product is mainly concentrated in DHA and also contains excellent organoleptic properties.
  • In September 2019, Epax is planning to make funding of $ 35 million in the next two years for implementing new developments in the omega-3 sector. This investment will allow Epax to have better capacity in the omega-3 sector at its main production site in Norway.
  • In May 2019, KD Pharma acquired a manufacturing site in the United Kingdom to increase its omega-3 supplement manufacturing capacity.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample